| # | Drug | Count |
|---|---|---|
| 0 | IPILIMUMAB | 143 |
| 1 | NIVOLUMAB | 131 |
| 2 | PEMBROLIZUMAB | 38 |
| 3 | ANTI ITCH | 17 |
| 4 | ANTI-ITCH | 17 |
| 5 | ANTI-ITCH CREAM | 17 |
| 6 | ANTI-PRURITIC | 17 |
| 7 | ANTIPRURITIC (ANTI-ITCH) | 17 |
| 8 | CARBOPLATIN | 17 |
| 9 | COOL RELIEF GEL WITH ALOE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INTERLEUKIN-10 | 5 | 0.0139 |
| 1 | HETASTARCH | 1 | 0.0059 |
| 2 | IPILIMUMAB | 143 | 0.0033 |
| 3 | BROMOCRIPTINE MESYLATE | 2 | 0.0031 |
| 4 | EPINEPHRINE HYDROCHLORIDE | 1 | 0.0021 |
| 5 | PEPPERMINT OIL | 2 | 0.0018 |
| 6 | DOBUTAMINE HYDROCHLORIDE | 2 | 0.0015 |
| 7 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 8 | NIVOLUMAB | 131 | 0.0013 |
| 9 | TALIMOGENE LAHERPAREPVEC | 2 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 148 | 0.0031 |
| 1 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 170 | 0.0017 |
| 3 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 8 | 0.0004 |
| 5 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 7 | Non-Standardized Plant Allergenic Extract [EPC] | 3 | 0.0002 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 4 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |